Back to Journals » Advances and Applications in Bioinformatics and Chemistry » Volume 17

RETRACTED ARTICLE: LAMP5, One of Four Genes Related to Oxidative Stress That Predict Biochemical Recurrence-Free Survival, Promotes Proliferation and Invasion in Prostate Cancer

Authors Wu P , Zhang J, Guo L, Chen B, Xiong L, Du Y

Received 4 September 2024

Accepted for publication 26 November 2024

Published 30 November 2024 Volume 2024:17 Pages 119—138

DOI https://doi.org/10.2147/AABC.S489131

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Maria Miteva



This paper has been retracted.

Wu P, Zhang J, Guo L, Chen B, Xiong L, Du Y. Adv Appl Bioinform Chem. 2024;17:119–138.

We, the authors and Publisher of the journal Advances and Applications in Bioinformatics and Chemistry are retracting the published article.

Since publication, the authors noticed that due to a parameter error in the R-based random forest analysis, LAMP5 was identified as the central gene instead of AURKA. As this error directly impacts the reported results and conclusions the authors alerted the issue to the Publisher, and all have agreed to retract the article to ensure correction of the scholarly record.

We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted articles will remain online to maintain the scholarly record, but they will be digitally watermarked on each page as “Retracted”.

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.